# Bharat Biotech is considering an initial public offering that could raise over USD 500 million.

*biotech · news · 2026-03-01 · Zee News*

## Key points

- Bharat Biotech is considering an IPO to raise over USD 500 million, sources report.
- The company plans Rs 200–250 crore capex in FY26 for a Sapigen Biologix facility in Odisha.
- Bharat Biotech's operating profit margin rose to 28.2% in FY25 from 8.8% in FY24.
- Government and UNICEF contracts are key revenues but expose Bharat Biotech to tender-driven volatility.
- India's pharma sector saw $3.5 billion in deal value with 72 transactions in Q3 2025.

**Companies:** Bharat Biotech
**Countries:** India

[Read the full story on Zee News](https://zeenews.india.com/economy/bharat-biotech-mulls-ipo-to-raise-over-usd-500-million-3022640.html)

---

Canonical: https://newsio.io/n/78e62760-2c7c-4aa6-8ccb-16ab76113970/bharat-biotech-is-considering-an-initial-public-offering-that-could-raise-over-u
Summarized by Newsio from Zee News. https://newsio.io/how-it-works